186 related articles for article (PubMed ID: 19225406)
1. Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy.
Boimel M; Grigoriadis N; Lourbopoulos A; Touloumi O; Rosenmann D; Abramsky O; Rosenmann H
J Neuropathol Exp Neurol; 2009 Mar; 68(3):314-25. PubMed ID: 19225406
[TBL] [Abstract][Full Text] [Related]
2. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
3. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
[TBL] [Abstract][Full Text] [Related]
4. Moderate environmental enrichment mitigates tauopathy in a neurofibrillary tangle mouse model.
Lahiani-Cohen I; Lourbopoulos A; Haber E; Rozenstein-Tsalkovich L; Abramsky O; Grigoriadis N; Rosenmann H
J Neuropathol Exp Neurol; 2011 Jul; 70(7):610-21. PubMed ID: 21666497
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice.
Kurata T; Miyazaki K; Kozuki M; Panin VL; Morimoto N; Ohta Y; Nagai M; Ikeda Y; Matsuura T; Abe K
Brain Res; 2011 Jan; 1371():161-70. PubMed ID: 21112317
[TBL] [Abstract][Full Text] [Related]
6. NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.
Shiryaev N; Jouroukhin Y; Giladi E; Polyzoidou E; Grigoriadis NC; Rosenmann H; Gozes I
Neurobiol Dis; 2009 May; 34(2):381-8. PubMed ID: 19264130
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury.
Wang H; Lynch JR; Song P; Yang HJ; Yates RB; Mace B; Warner DS; Guyton JR; Laskowitz DT
Exp Neurol; 2007 Jul; 206(1):59-69. PubMed ID: 17521631
[TBL] [Abstract][Full Text] [Related]
8. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.
Siegel GJ; Chauhan NB; Feinstein DL; Li G; Larson EB; Breitner JC; Montine TJ
Neurology; 2008 Jul; 71(5):383; author reply 383. PubMed ID: 18663190
[No Abstract] [Full Text] [Related]
9. The influence of simvastatin, atorvastatin and high-cholesterol diet on acetylcholinesterase activity, amyloid beta and cholesterol synthesis in rat brain.
Cibickova L; Hyspler R; Micuda S; Cibicek N; Zivna H; Jun D; Ticha A; Brcakova E; Palicka V
Steroids; 2009 Jan; 74(1):13-9. PubMed ID: 18817797
[TBL] [Abstract][Full Text] [Related]
10. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat.
Birnbaum Y; Lin Y; Ye Y; Merla R; Perez-Polo JR; Uretsky BF
J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):72-9. PubMed ID: 18287593
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol synthesis in central nervous system of rat is affected by simvastatin as well as by atorvastatin.
Cibickova L; Hyspler R; Ticha A; Cibicek N; Palicka V; Cermakova E; Zadak Z
Pharmazie; 2008 Nov; 63(11):819-22. PubMed ID: 19069243
[TBL] [Abstract][Full Text] [Related]
13. Effects of HMG-CoA reductase inhibitors on learning and memory in the guinea pig.
Maggo S; Ashton JC
Eur J Pharmacol; 2014 Jan; 723():294-304. PubMed ID: 24296319
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin and pitavastatin reduce senile plaques and inflammatory responses in a mouse model of Alzheimer's disease.
Kurata T; Miyazaki K; Kozuki M; Morimoto N; Ohta Y; Ikeda Y; Abe K
Neurol Res; 2012 Jul; 34(6):601-10. PubMed ID: 22732109
[TBL] [Abstract][Full Text] [Related]
15. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.
Li G; Larson EB; Sonnen JA; Shofer JB; Petrie EC; Schantz A; Peskind ER; Raskind MA; Breitner JC; Montine TJ
Neurology; 2007 Aug; 69(9):878-85. PubMed ID: 17724290
[TBL] [Abstract][Full Text] [Related]
16. The effect of exogenous cholesterol and lipid-modulating agents on enterocytic amyloid-beta abundance.
Pallebage-Gamarallage MM; Galloway S; Johnsen R; Jian L; Dhaliwal S; Mamo JC
Br J Nutr; 2009 Feb; 101(3):340-7. PubMed ID: 18631412
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice.
Boimel M; Grigoriadis N; Lourbopoulos A; Haber E; Abramsky O; Rosenmann H
Exp Neurol; 2010 Aug; 224(2):472-85. PubMed ID: 20546729
[TBL] [Abstract][Full Text] [Related]
18. Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology.
Leroy K; Ando K; Héraud C; Yilmaz Z; Authelet M; Boeynaems JM; Buée L; De Decker R; Brion JP
J Alzheimers Dis; 2010; 19(2):705-19. PubMed ID: 20110614
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
Turner NA; Midgley L; O'Regan DJ; Porter KE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of Candida species and Aspergillus fumigatus by statins.
Macreadie IG; Johnson G; Schlosser T; Macreadie PI
FEMS Microbiol Lett; 2006 Sep; 262(1):9-13. PubMed ID: 16907733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
